Metformin Hydrochloride has 38 known drug interactions based on U.S. FDA drug labeling data. 12 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Acetazolamide, Alcohol, Cimetidine. Patients taking Metformin Hydrochloride should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 38
- Major
- 12
- Moderate
- 25
Major (12)
- Metformin Hydrochloride + Acetazolamide— Carbonic anhydrase inhibitor that may increase risk of lactic acidosis by decreasing serum bicarbonate and inducing meta…
- Metformin Hydrochloride + Alcohol— Potentiates metformin's effect on lactate metabolism, increasing risk of lactic acidosis.
- Metformin Hydrochloride + Cimetidine— OCT2/MATE inhibitor that reduces metformin clearance and may increase risk of lactic acidosis through increased systemic…
- Metformin Hydrochloride + Dichlorphenamide— Carbonic anhydrase inhibitor that may increase risk of lactic acidosis by decreasing serum bicarbonate and inducing meta…
- Metformin Hydrochloride + Dolutegravir— OCT2/MATE inhibitor that reduces metformin clearance and may increase risk of lactic acidosis through increased systemic…
- Metformin Hydrochloride + Insulin Human— Coadministration with metformin may increase risk of hypoglycemia.
- Metformin Hydrochloride + Mao Inhibitors— May increase risk of lactic acidosis with metformin. Consider more frequent monitoring.
- Metformin Hydrochloride + Ranolazine— OCT2/MATE inhibitor that reduces metformin clearance and may increase risk of lactic acidosis through increased systemic…
- Metformin Hydrochloride + Sulfonylurea— Insulin secretagogue that when combined with metformin may increase risk of hypoglycemia.
- Metformin Hydrochloride + Topiramate— Carbonic anhydrase inhibitor that may increase risk of lactic acidosis by decreasing serum bicarbonate and inducing meta…
- Metformin Hydrochloride + Vandetanib— OCT2/MATE inhibitor that reduces metformin clearance and may increase risk of lactic acidosis through increased systemic…
- Metformin Hydrochloride + Zonisamide— Carbonic anhydrase inhibitor that may increase risk of lactic acidosis by decreasing serum bicarbonate and inducing meta…
Moderate (25)
- Metformin Hydrochloride + Amiloride— Cationic drug eliminated by renal tubular secretion with potential for interaction with metformin by competing for commo…
- Metformin Hydrochloride + Andthiazide— Diuretic that may cause hyperglycemia and loss of glycemic control; monitor blood glucose closely.
- Metformin Hydrochloride + Calcium Channel Blockers— Drugs that produce hyperglycemia and may lead to loss of glycemic control; monitor blood glucose.
- Metformin Hydrochloride + Corticosteroids— Drugs that produce hyperglycemia and may lead to loss of glycemic control; monitor blood glucose.
- Metformin Hydrochloride + Digoxin— Cationic drug eliminated by renal tubular secretion with potential for interaction with metformin by competing for commo…
- Metformin Hydrochloride + Estrogens— Drugs that produce hyperglycemia and may lead to loss of glycemic control; monitor blood glucose.
- Metformin Hydrochloride + Furosemide— Furosemide increased metformin plasma and blood Cmax by 22% and blood AUC by 15%. Metformin decreased furosemide Cmax by…
- Metformin Hydrochloride + Glibenclamide— Coadministration resulted in decreases in glyburide AUC and Cmax that were highly variable. Clinical significance uncert…
- Metformin Hydrochloride + Isoniazid— Drugs that produce hyperglycemia and may lead to loss of glycemic control; monitor blood glucose.
- Metformin Hydrochloride + Morphine— Cationic drug eliminated by renal tubular secretion with potential for interaction with metformin by competing for commo…
- Metformin Hydrochloride + Niacin— Drugs that produce hyperglycemia and may lead to loss of glycemic control; monitor blood glucose.
- Metformin Hydrochloride + Nifedipine— Nifedipine increased metformin plasma Cmax by 20% and AUC by 9%, with increased urinary excretion. Tmax and half-life un…
- Metformin Hydrochloride + Oral Contraceptives— Drugs that produce hyperglycemia and may lead to loss of glycemic control; monitor blood glucose.
- Metformin Hydrochloride + Phenothiazine Antipsychotics— Produces hyperglycemia and may lead to loss of glycemic control. Monitor blood glucose closely.
- Metformin Hydrochloride + Phenothiazines— Drugs that produce hyperglycemia and may lead to loss of glycemic control; monitor blood glucose.
- Metformin Hydrochloride + Phenytoin— Drugs that produce hyperglycemia and may lead to loss of glycemic control; monitor blood glucose.
- Metformin Hydrochloride + Procainamide— Cationic drug eliminated by renal tubular secretion with potential for interaction with metformin by competing for commo…
- Metformin Hydrochloride + Quinidine— Cationic drug eliminated by renal tubular secretion with potential for interaction with metformin by competing for commo…
- Metformin Hydrochloride + Quinine— Cationic drug eliminated by renal tubular secretion with potential for interaction with metformin by competing for commo…
- Metformin Hydrochloride + Ranitidine— Cationic drug eliminated by renal tubular secretion with potential for interaction with metformin by competing for commo…
- Metformin Hydrochloride + Thiazides— Diuretics that produce hyperglycemia and may lead to loss of glycemic control; monitor blood glucose.
- Metformin Hydrochloride + Thyroid— Drugs that produce hyperglycemia and may lead to loss of glycemic control; monitor blood glucose.
- Metformin Hydrochloride + Triamterene— Cationic drug eliminated by renal tubular secretion with potential for interaction with metformin by competing for commo…
- Metformin Hydrochloride + Trimethoprim— Cationic drug eliminated by renal tubular secretion with potential for interaction with metformin by competing for commo…
- Metformin Hydrochloride + Vancomycin— Cationic drug eliminated by renal tubular secretion with potential for interaction with metformin by competing for commo…